Abstract
In recent decades, there has been considerable amount of information about embryonic stem cells (ES). The dilemma facing scientists interested in the development and use of human stem cells in replacement therapies is the source of these cells, i.e. the human embryo. There are many ethical and moral problems related to the use of these cells. Hematopoietic stem cells from umbilical cord blood have been proposed as an alternative source of embryonic stem cells. After exposure to different agents, these cells are able to express antigens of diverse cellular lineages, including the neural type. The In vitro manipulation of human umbilical cord blood (hUCB) cells has shown their stem capacity and plasticity. These cells are easily accessible, In vitro amplifiable, well tolerated by the host, and with more primitive molecular characteristics that give them great flexibility. Overall, these properties open a promising future for the use of hUCB in regenerative therapies for the Central Nervous System (CNS). This review will focus on the available literature concerning umbilical cord blood cells as a therapeutic tool for the treatment of neurodegenerative diseases.
Keywords: Stem cells, umbilical cord blood, neuroregeneration, CNS transplantation, brain injury, neurodegenerative disorders
Current Stem Cell Research & Therapy
Title: Applications of Human Umbilical Cord Blood Cells in Central Nervous System Regeneration
Volume: 5 Issue: 1
Author(s): Antonio S. Herranz, Rafael Gonzalo-Gobernado, Diana Reimers, Maria J. Asensio, Macarena Rodriguez-Serrano and Eulalia Bazan
Affiliation:
Keywords: Stem cells, umbilical cord blood, neuroregeneration, CNS transplantation, brain injury, neurodegenerative disorders
Abstract: In recent decades, there has been considerable amount of information about embryonic stem cells (ES). The dilemma facing scientists interested in the development and use of human stem cells in replacement therapies is the source of these cells, i.e. the human embryo. There are many ethical and moral problems related to the use of these cells. Hematopoietic stem cells from umbilical cord blood have been proposed as an alternative source of embryonic stem cells. After exposure to different agents, these cells are able to express antigens of diverse cellular lineages, including the neural type. The In vitro manipulation of human umbilical cord blood (hUCB) cells has shown their stem capacity and plasticity. These cells are easily accessible, In vitro amplifiable, well tolerated by the host, and with more primitive molecular characteristics that give them great flexibility. Overall, these properties open a promising future for the use of hUCB in regenerative therapies for the Central Nervous System (CNS). This review will focus on the available literature concerning umbilical cord blood cells as a therapeutic tool for the treatment of neurodegenerative diseases.
Export Options
About this article
Cite this article as:
Herranz S. Antonio, Gonzalo-Gobernado Rafael, Reimers Diana, Asensio J. Maria, Rodriguez-Serrano Macarena and Bazan Eulalia, Applications of Human Umbilical Cord Blood Cells in Central Nervous System Regeneration, Current Stem Cell Research & Therapy 2010; 5 (1) . https://dx.doi.org/10.2174/157488810790442822
DOI https://dx.doi.org/10.2174/157488810790442822 |
Print ISSN 1574-888X |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3946 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Bone Imaging in Metastatic Castration-resistant Prostate Cancer; Where do we Stand
Current Radiopharmaceuticals Skeletal Survey in Multiple Myeloma: Role of Imaging
Current Medical Imaging Biopolymer-based Scaffolds for Tissue Engineering Applications
Current Drug Targets The Timing of Drug Administration for Thromboprophylaxis Following Orthopaedic Surgery: Evidence and Controversies Related to Treatment Initiation and Duration
Current Vascular Pharmacology Phosphodiesterase 5 Inhibitors in the Treatment of Erectile Dysfunction
Current Pharmaceutical Design The Emerging Roles of Leptin and Ghrelin in Cardiovascular Physiology and Pathophysiology
Current Vascular Pharmacology Calcium Homeostasis Following Traumatic Neuronal Injury
Current Neurovascular Research Novel Neuroendocrine and Metabolic Mechanism Provides the Patented Platform for Important Rejuvenation Therapies: Targeted Therapy of Telomere Attrition and Lifestyle Changes of Telomerase Activity with the Timing of Neuron-Specific Imidazole-Containing Dipeptide-Dominant Pharmaconutrition Provision
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Chemotherapy for Prostate Cancer
Current Pharmaceutical Design Patent Selections
Recent Patents on Biotechnology The Role of Blood-Brain Barrier Studies in the Pharmaceutical Industry
Current Drug Metabolism Bisphosphonates as Treatment of Bone Metastases
Current Pharmaceutical Design Involvement of Cytosolic Phospholipase A2, Calcium Independent Phospholipase A2 and Plasmalogen Selective Phospholipase A2 in Neurodegenerative and Neuropsychiatric Conditions
Current Medicinal Chemistry Pulmonary Circulation and Pulmonary Function in Neonatal Lung Hypoplasia:Treatment with Corticosteroids
Current Pediatric Reviews Deformable Surfactant Vesicles Loading Ammonium Glycyrrhizinate: Characterization and In Vitro Permeation Studies
Letters in Drug Design & Discovery Restless Legs Syndrome/Willis-Ekbom Disease and Periodic Limb Movements: A Comprehensive Review of Epidemiology, Pathophysiology, Diagnosis and Treatment Considerations
Current Rheumatology Reviews Green Tea, A Medicinal Food with Promising Neurological Benefits
Current Neuropharmacology Phytochemicals for Breast Cancer Therapy: Current Status and Future Implications
Current Cancer Drug Targets Proliposomes for Oral Delivery: Progress and Challenges
Current Pharmaceutical Biotechnology Primary Tumors of the Sacrum: Imaging Findings
Current Medical Imaging